Advice on the anticonvulsant drugs Pregabalin and Gabapentin

The chair of the Advisory Council on the Misuse of Drugs writes to Karen Bradley about Pregabalin and Gabapentin.


ACMD advice on Pregabalin and Gabapentin

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email Please tell us what format you need. It will help us if you say what assistive technology you use.


Les Iversen, chair of the ACMD, writes to Karen Bradley, Minister for Preventing Abuse and Exploitation, recommending that Pregabalin and Gabapentin be made class C controlled substances.

Read the consultation outcome for the proposal to schedule Pregabalin and Gabapentin under the Misuse of Drugs Regulations 2001 on the National Archives website.

Updates to this page

Published 14 January 2016
Last updated 17 October 2018 + show all updates
  1. Addendum to section 6 of the advice published.

  2. First published.

Sign up for emails or print this page